Breath biomarkers in idiopathic pulmonary fibrosis: a systematic review

[1] Hutchinson J(2015)Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review Eur Respir J 46 795-806

[2] Fogarty A(2011)An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management Am J Respir Crit Care Med 183 788-824

[3] Hubbard R(2015)Challenges in IPF diagnosis, current management and future perspectives Sarcoidosis Vasc Diffuse Lung Dis 32 28-35

[4] McKeever T(2018)American Thoracic society ERSJRS, Latin American Thoracic S. diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline Am J Respir Crit Care Med 198 e44-e68

[5] Raghu G(2004)Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? Am J Respir Crit Care Med 170 904-910

[6] Collard HR(2016)Interobserver agreement for the ATS/ERS/JRS/ALAT criteria for a UIP pattern on CT Thorax 71 45-51

[7] Egan JJ(2016)Surgical lung biopsy for the diagnosis of interstitial lung disease in England: 1997–2008 Eur Respir J 48 1453-1461

[8] Martinez FJ(1998)Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 157 199-203

[9] Behr J(2011)Clinical course and prediction of survival in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 183 431-440

[10] Brown KK(2012)Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials Am J Respir Crit Care Med 185 1044-1048

[1] Hutchinson J(2015)Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review Eur Respir J 46 795-806

[2] Fogarty A(2011)An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management Am J Respir Crit Care Med 183 788-824

[3] Hubbard R(2015)Challenges in IPF diagnosis, current management and future perspectives Sarcoidosis Vasc Diffuse Lung Dis 32 28-35

[4] McKeever T(2018)American Thoracic society ERSJRS, Latin American Thoracic S. diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline Am J Respir Crit Care Med 198 e44-e68

[5] Raghu G(2004)Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? Am J Respir Crit Care Med 170 904-910

[6] Collard HR(2016)Interobserver agreement for the ATS/ERS/JRS/ALAT criteria for a UIP pattern on CT Thorax 71 45-51

[7] Egan JJ(2016)Surgical lung biopsy for the diagnosis of interstitial lung disease in England: 1997–2008 Eur Respir J 48 1453-1461

[8] Martinez FJ(1998)Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 157 199-203

[9] Behr J(2011)Clinical course and prediction of survival in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 183 431-440

[10] Brown KK(2012)Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials Am J Respir Crit Care Med 185 1044-1048